Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA257785
Max Phase: Preclinical
Molecular Formula: C28H33ClN8O4
Molecular Weight: 581.08
Molecule Type: Small molecule
Associated Items:
ID: ALA257785
Max Phase: Preclinical
Molecular Formula: C28H33ClN8O4
Molecular Weight: 581.08
Molecule Type: Small molecule
Associated Items:
Synonyms (1): MRS-5166
Synonyms from Alternative Forms(1):
Canonical SMILES: CNC(=O)[C@@]12C[C@@H]1[C@@H](n1cnc3c(NCc4cccc(Cl)c4)nc(C#CCCCC(=O)NCCN)nc31)[C@H](O)[C@@H]2O
Standard InChI: InChI=1S/C28H33ClN8O4/c1-31-27(41)28-13-18(28)22(23(39)24(28)40)37-15-34-21-25(33-14-16-6-5-7-17(29)12-16)35-19(36-26(21)37)8-3-2-4-9-20(38)32-11-10-30/h5-7,12,15,18,22-24,39-40H,2,4,9-11,13-14,30H2,1H3,(H,31,41)(H,32,38)(H,33,35,36)/t18-,22-,23+,24+,28+/m1/s1
Standard InChI Key: YREVRKNBIMSBSA-JIGPFOKVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 581.08 | Molecular Weight (Monoisotopic): 580.2313 | AlogP: 0.72 | #Rotatable Bonds: 10 |
Polar Surface Area: 180.31 | Molecular Species: BASE | HBA: 10 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 13.12 | CX Basic pKa: 9.16 | CX LogP: 0.73 | CX LogD: -1.03 |
Aromatic Rings: 3 | Heavy Atoms: 41 | QED Weighted: 0.15 | Np Likeness Score: -0.22 |
1. Melman A, Gao ZG, Kumar D, Wan TC, Gizewski E, Auchampach JA, Jacobson KA.. (2008) Design of (N)-methanocarba adenosine 5'-uronamides as species-independent A3 receptor-selective agonists., 18 (9): [PMID:18424135] [10.1016/j.bmcl.2008.04.001] |
Source(1):